Federal Register / Vol. 77, No. 37 / Friday, February 24, 2012 / Notices 11125 

ESTIMATED BURDEN TABLE

Projects Number of 

respondents 

Number of 

responses per 

respondent 

Average 

hours per 

response 

Response 

burden 

QDRL Interviews ................................................................................................ 9000 1 1 9000 

Focus groups ..................................................................................................... 300 1 1 .5 450 

Total ............................................................................................................ ........................ ........................ ...................... 9450 

Kimberly Lane, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2012–4378 Filed 2–23–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60 Day–12–12ET] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–7570 and 

send comments to Kimberly Lane, CDC 

Reports Clearance Officer, 1600 Clifton 

Road, MS–D74, Atlanta, GA 30333 or 

send an email to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Communications Research to Inform 

Messages and Materials about 

Cytomegalovirus (CMV)—NEW— 

Prevention Research Branch, National 

Center on Birth Defects and 

Developmental Disabilities (NCBDDD), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Cytomegalovirus (CMV) is the most 

common congenital infection in the 

U.S., causing disabilities in more than 

5,500 children born each year (CDC, 

2010). Disabilities related to congenital 

CMV are more common than other wellknown childhood conditions, such as 

Down syndrome, fetal alcohol 

syndrome, and neural tube defects, and 

can include hearing or vision loss, 

mental retardation, psychomotor delays, 

and speech and language impairment. 

This is a multiphase communication 

research study that will help inform 

CDC’s development materials and 

prevention messaging about congenital 

CMV. The information collection 

activities will consist of focus groups 

and an online survey. First, we plan to 

conduct 8 focus groups with 9 

respondents each to identify potential 

messaging frames for communicating 

information about congenital CMV to 

the target audiences and adopting CMV 

preventive guidelines. We estimate that 

we will screen 144 women between the 

ages of 18–40 who are either pregnant 

or plan to get pregnant in the next 12 

months, and who have a child under age 

5, in order to recruit 72 participants for 

the focus groups. These focus groups 

will be conducted in Atlanta, Georgia 

(4) and San Diego, California (4). 

Findings from the focus groups will 

inform revisions to existing CDC 

messages and materials, which will be 

further tested in the second information 

collection activity, the online survey. 

Phase II research will include an online 

survey to test the revised messages and 

materials. This web survey will: (1) 

Examine baseline awareness and 

knowledge regarding CMV, (2) assess 

baseline CMV prevention behaviors 

prior to viewing CMV communication 

interventions (factsheet and video), (3) 

assess appeal and evaluate the impact of 

CMV communication interventions on 

their attitudes, beliefs, and behavioral 

intentions regarding prevention 

behaviors and (4) assess knowledge, 

attitudes and behaviors pre- and postinterventions with a larger target 

audience sample (N=500). We estimate 

that we will screen 3,000 women in 

order to recruit 500 respondents for the 

online survey. 

All survey responses (100%) will be 

submitted through a secure survey Web 

site established for this project. No 

Information in Identifiable Form (IIF) 

collected will be transmitted to CDC. 

The only IIF being collected (respondent 

name, address, and phone number) is to 

be used by the focus group facilities to 

screen potential respondents to 

determine eligibility for the focus 

groups. The total estimated annual 

burden is 531 hours. There are no costs 

to the respondents other than their time. 

This request is submitted to obtain 

OMB clearance for one year. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Phase I: Focus Groups 

Women (age 18–40) ......................... Participant Screener ......................... 144 1 5/60 12 

Demographic questionnaire ............. 72 1 15/60 18 

Informed consent form ..................... 72 1 15/60 18 


srobinson on DSK4SPTVN1PROD with NOTICES
11126 Federal Register / Vol. 77, No. 37 / Friday, February 24, 2012 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Focus group ..................................... 72 1 90/60 108 

Phase II: Web Survey 

Women (age 18–40) ......................... Participant screener ......................... 3,000 1 5/60 250 

Web Survey ...................................... 500 1 15/60 125 

Total ........................................... ........................................................... ........................ ........................ ........................ 531 

Kimberly S. Lane, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2012–4380 Filed 2–23–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60 Day-12–0210] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–7570 or send 

comments to Kimberly Lane, CDC 

Reports Clearance Officer, 1600 Clifton 

Road, MS D–74, Atlanta, GA 30333 or 

send an email to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

List of Ingredients Added to Tobacco 

in the Manufacture of Cigarette 

Products—Extension—Office on 

Smoking and Health, National Center 

for Chronic Disease Prevention and 

Health Promotion (NCCDPHP), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

Cigarette smoking is the leading 

preventable cause of premature death 

and disability in the United States. Each 

year, more than 440,000 premature 

deaths occur as the result of diseases 

related to cigarette smoking. The 

Centers for Disease Control and 

Prevention (CDC), Office on Smoking 

and Health (OSH) has the primary 

responsibility for the Department of 

Health and Human Services (HHS) 

smoking and health program. HHS’s 

overall goal is to reduce death and 

disability resulting from cigarette 

smoking and other forms of tobacco use 

through programs of information, 

education and research. 

The Comprehensive Smoking 

Education Act of 1984 (CSEA, 15 U.S.C. 

1336 or Pub. L. 98–474) requires each 

person who manufactures, packages, or 

imports cigarettes to provide the 

Secretary of Health and Human Services 

(HHS) with a list of ingredients added 

to tobacco in the manufacture of 

cigarettes. The legislation also 

authorizes HHS to undertake research, 

and to report to the Congress (as deemed 

appropriate) discussing the health 

effects of these ingredients. 

HHS has delegated responsibility for 

implementing the CSEA’s ingredient 

reporting requirements to CDC’s Office 

on Smoking and Health (OSH). OSH has 

collected ingredient reports on cigarette 

products since 1986. Respondents are 

commercial cigarette manufacturers, 

packagers, or importers, or their 

designated representatives. Respondents 

are not required to submit specific 

forms, however, they are required to 

submit a list of all ingredients used in 

their products. CDC requires the 

ingredient report to be submitted by 

chemical name and Chemical Abstract 

Service (CAS) Registration Number, 

consistent with accepted reporting 

practices for other companies currently 

required to report ingredients added to 

other consumer products. Typically, 

respondents submit a summary report to 

CDC with the ingredient information for 

multiple products, or a statement that 

there are no changes to their previously 

submitted ingredient report. The 

estimated burden per response is 6.5 

hours. 

Ingredient reports for new products 

are due at the time of first importation. 

Thereafter, ingredient reports are due 

annually on March 31. Information is 

submitted to OSH by mailing a written 

report on the respondent’s letterhead, by 

CD, three-inch floppy disk, or thumb 

drive. Electronic mail submissions are 

not accepted. Upon receipt and 

verification of the annual ingredient 

report, OSH issues a Certificate of 

Compliance to the respondent. 

There are no costs to respondents 

other than their time. 


srobinson on DSK4SPTVN1PROD with NOTICES